Neoadjuvant therapy in gynaecological malignancies: What pathologists need to know
Neoadjuvant therapy in gynaecological malignancies: What pathologists need to know
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and Association of Clinical Pathologists
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and Association of Clinical Pathologists
Subjects
More information
Scope and Contents
Contents
In recent times, there has been a growing tendency to treat advanced gynaecological malignancies with neoadjuvant chemotherapy (NACT), with the goal of reducing tumour volume and enhancing operability resulting in optimal cytoreduction. This approach is used in particular for patients with advanced high-grade serous carcinoma of the ovary, fallopia...
Alternative Titles
Full title
Neoadjuvant therapy in gynaecological malignancies: What pathologists need to know
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2179426127
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2179426127
Other Identifiers
ISSN
0021-9746
E-ISSN
1472-4146
DOI
10.1136/jclinpath-2018-205634
